Tweet
FOR IMMEDIATE RELEASE
October 17, 2012
Contact:
Jon Ebelt, Public Information Officer, DPHHS, (406) 444-0936
Chuck Council, Communications Specialist, DPHHS, (406) 444-4391
DPHHS, public health agencies respond to federal recall of all products associated with multi-state fungal meningitis outbreak
DPHHS requests Montana healthcare providers contact patients
The Department of Public Health and Human Services (DPHHS), public health agencies and private clinics in Montana are supporting the Food and Drug Administration?s (FDA) recall of all products from the New England Compounding Center (NECC).
This recall is part of the on-going multi-state fungal meningitis outbreak that is being investigated by the Centers for Disease Control and Prevention (CDC) and the FDA.
While there is no indication that contaminated products came to Montana, all products from NECC were recently recalled out of an abundance of caution.
No related illnesses have been identified in any Montana resident at this time.
To help ensure public health authorities and federal regulators become aware of any additional problems, clinicians who injected patients with any product from NECC are asked to notify these recipients and determine if any complications are present.
Pain reduction medications produced by NECC have been linked to 233 cases of fungal meningitis and 15 deaths in 15 states, according to the CDC.
Symptoms of meningitis may include a new or worsening headache, dizziness, fever, nausea, and sensitivity to light. A number of people who became ill also had symptoms of stroke, such as weakness or difficulty with speech. Most of the illnesses are being reported one to four weeks after the injection was received. This form of meningitis is not contagious.
Because the situation continues to develop as the FDA and CDC investigation expands, the list of products and clinics receiving products distributed by NECC may grow. Updated information is available at the DPHHS web site: www.dphhs.mt.gov
October 17, 2012
Contact:
Jon Ebelt, Public Information Officer, DPHHS, (406) 444-0936
Chuck Council, Communications Specialist, DPHHS, (406) 444-4391
DPHHS, public health agencies respond to federal recall of all products associated with multi-state fungal meningitis outbreak
DPHHS requests Montana healthcare providers contact patients
The Department of Public Health and Human Services (DPHHS), public health agencies and private clinics in Montana are supporting the Food and Drug Administration?s (FDA) recall of all products from the New England Compounding Center (NECC).
This recall is part of the on-going multi-state fungal meningitis outbreak that is being investigated by the Centers for Disease Control and Prevention (CDC) and the FDA.
While there is no indication that contaminated products came to Montana, all products from NECC were recently recalled out of an abundance of caution.
No related illnesses have been identified in any Montana resident at this time.
To help ensure public health authorities and federal regulators become aware of any additional problems, clinicians who injected patients with any product from NECC are asked to notify these recipients and determine if any complications are present.
Pain reduction medications produced by NECC have been linked to 233 cases of fungal meningitis and 15 deaths in 15 states, according to the CDC.
Symptoms of meningitis may include a new or worsening headache, dizziness, fever, nausea, and sensitivity to light. A number of people who became ill also had symptoms of stroke, such as weakness or difficulty with speech. Most of the illnesses are being reported one to four weeks after the injection was received. This form of meningitis is not contagious.
Because the situation continues to develop as the FDA and CDC investigation expands, the list of products and clinics receiving products distributed by NECC may grow. Updated information is available at the DPHHS web site: www.dphhs.mt.gov
